
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Adenylate cyclase 10/ADCY10 CRISPR/Cas9 KO Plasmid (h) | sc-406235 | 20 µg | $397.00 |
ADCY10 encodes adenylate cyclase 10 (soluble adenylyl cyclase, sAC), an intracellular enzyme that generates cyclic AMP in response to bicarbonate and calcium signals rather than G protein–coupled receptor activation. By shaping cAMP microdomains, ADCY10 modulates PKA and EPAC signaling, influencing processes such as mitochondrial function, ion transport, sperm capacitation, and pH-sensing responses. sAC-derived cAMP integrates metabolic and acid–base cues with phosphorylation networks, affecting transcriptional programs and cellular stress adaptation. Dysregulated ADCY10 activity has been investigated in contexts including male infertility, renal and airway bicarbonate handling, and tumor-associated cAMP signaling rewiring, supporting its relevance for mechanistic pathway studies.
Adenylate cyclase 10/ADCY10 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the ADCY10 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the ADCY10 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the ADCY10 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Adenylate cyclase 10/ADCY10 protein expression.
This CRISPR knockout system enables efficient generation of ADCY10-deficient cell models for investigation of Adenylate cyclase 10/ADCY10 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.